YMAB

Y mAbs Therapeutics Stock Price

49.995
1.81 (3.75%)
Upgrade to Real-Time
Regular Market
49.995
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Y mAbs Therapeutics Inc YMAB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.81 3.75% 49.995 12:30:31
Open Price Low Price High Price Close Price Previous Close
48.56 47.87 50.567 48.19
Bid Price Ask Price Spread News
49.89 50.10 0.21 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,468 168,214 $ 49.13 $ 8,263,808 174,213 14.16 - 55.36
Last Trade Time Type Quantity Stock Price Currency
12:30:31 25 $ 49.995 USD

Y mAbs Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.03B 40.51M 30.41M $ - $ - -2.31 -15.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -74.00k 1.10%

more financials information »

Y mAbs Therapeutics News

Date Time Source News Article
11/25/202017:30Edgar (US Regulatory)Current Report Filing (8-k)
11/25/202017:02GlobeNewswire Inc.FDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the..
11/20/202016:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
11/19/202010:33Edgar (US Regulatory)Current Report Filing (8-k)
11/19/202009:00GlobeNewswire Inc.Y-mAbs Announces Update on Omburtamab in DIPG
11/17/202016:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
11/05/202017:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical YMAB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week41.8051.9940.0945.26263,9538.2019.61%
1 Month43.3055.3639.9045.61215,7956.7015.46%
3 Months37.5155.3636.1142.14174,91412.4933.28%
6 Months38.1155.3633.7142.25184,68411.8931.19%
1 Year34.1055.3614.1635.76208,04415.9046.61%
3 Years26.5055.3614.1630.98173,67523.5088.66%
5 Years26.5055.3614.1630.98173,67523.5088.66%

Y mAbs Therapeutics Description

Y-mAbs Therapeutics Inc is a late-stage clinical biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Products developed by the company include naxitamab for the treatment of pediatric patients with relapsed or refractory and radiolabeled omburtamab for the treatment of pediatric patients with central nervous system.
Your Recent History
NASDAQ
YMAB
Y mAbs The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201130 17:47:02